Athersys will be participating in the virtual Locust Walk Stem Cell Conference.
B.J. Lehmann, President and Chief Operating Officer, will present a corporate overview on Monday, April 11, 2022 at 2:00 p.m. ET. Mr. Lehmann will discuss the Company’s investigational clinical product platform, MultiStem® (invimestrocel) cell therapy. The Company’s management team will also participate in one-on-one meetings with institutional investors during the conference. Those interested in viewing the presentation can do so on the day of the event
here.